Does vitamin B12 deficiency with elevated methylmalonic acid indicate impaired mitochondrial fatty acid and amino acid metabolism?

In patients presenting with vitamin B12 deficiency, elevated methylmalonic acid (MMA) is not merely a passive diagnostic marker but a direct indicator of compromised mitochondrial bioenergetics.

Biochemical mechanisms of metabolic impairment

• Cofactor Depletion: Vitamin B12, in the form of adenosylcobalamin, serves as an essential cofactor for the mitochondrial enzyme methylmalonyl-CoA mutase (MCM/MMUT). B12 deficiency depletes this cofactor, inactivating MCM.
• Metabolic Blockade: Under normal conditions, MCM converts L-methylmalonyl-CoA to succinyl-CoA. Inactivation of this enzyme halts the pathway, preventing the proper catabolism and entry of odd-chain fatty acids, cholesterol, and branched-chain amino acids (such as valine and isoleucine) into the tricarboxylic acid (TCA) cycle.
• MMA Accumulation: As a consequence of this pathway block, upstream methylmalonyl-CoA accumulates and is hydrolyzed into MMA, which then rises in tissues, blood, and urine.

Bioenergetic and mitochondrial consequences

• Direct Enzymatic Inhibition: Rather than remaining a benign byproduct, accumulated MMA acts as a direct mitochondrial toxin. It actively inhibits succinate dehydrogenase (Complex II of the electron transport chain) and alpha-ketoglutarate dehydrogenase.
• Respiratory Dysfunction: This secondary inhibition disrupts the TCA cycle and impairs oxidative phosphorylation. The dual effect of a primary pathway block and direct respiratory chain inhibition severely compromises the cell's capacity to generate ATP from fatty acids and amino acids.

Bottom line

• Elevated MMA in vitamin B12 deficiency represents a functional metabolic bottleneck that impairs the utilization of branched-chain amino acids and odd-chain fatty acids. Because accumulated MMA actively inhibits mitochondrial Complex II and the TCA cycle, this deficiency drives cellular energetic stress, highlighting the clinical importance of correcting B12 status to restore mitochondrial respiratory function.